Clinical Oncology Next Generation Sequencing Market 2023-2032 Growth, Analysis Report, Share, Trends

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Clinical Oncology Next Generation Sequencing Global Market Report 2023 identifies rise in the number of cancer cases as the major driver for the Clinical Oncology Next Generation Sequencing market's growth in the forecast period. According to the American Cancer Society, there were 1.9 million new cases and 0.6 million cancer deaths in 2021 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases.

The global clinical oncology next-generation sequencing market grew from $0.39 billion in 2022 to $0.45 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of clinical oncology next-generation sequencing is expected to grow from $0.75 billion in 2027 at a CAGR of 13.7%.

Download Free Sample Of Clinical Oncology Next Generation Sequencing Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=3344&type=smp

Major competitors in the Clinical Oncology Next Generation Sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina.

A key trend in the Clinical Oncology Next Generation Sequencing market includes high costs associated. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In low-income countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. According to an article published in 2020 by Genetics in Medicine, the genome sequencing costs per cancer case is around £6,841, and costs per rare disease are around £7,050.

Read More On The Global Clinical Oncology Next Generation Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

The Clinical Oncology Next Generation Sequencing market is segmented -
• By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing
• By Application: Screening, Companion Diagnostics, Other Diagnostics
• By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Clinical Oncology Next Generation Sequencing market.

The Business Research Company's "Global Clinical Oncology Next Generation Sequencing Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Clinical Oncology Next Generation Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3344

The Table Of Content For The Clinical Oncology Next Generation Sequencing Market Include:

1. Executive Summary
2. Clinical Oncology Next Generation Sequencing Market Characteristics
3. Clinical Oncology Next Generation Sequencing Market Trends And Strategies
4. Clinical Oncology Next Generation Sequencing Market - Macro Economic Scenario
5. Clinical Oncology Next Generation Sequencing Market Size And Growth
………………………………………………………………
26. Africa Clinical Oncology Next Generation Sequencing Market
27. Clinical Oncology Next Generation Sequencing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Market
29. Clinical Oncology Next Generation Sequencing Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
Twitter:https://twitter.com/tbrc_info
Facebook:https://www.facebook.com/TheBusinessResearchCompany
YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog:https://blog.tbrc.info/
Healthcare Blog:https://healthcareresearchreports.com/
Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases:https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultantsspecialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.